Evidence map›Paper›PMID 39161102›Full record

ReviewGut microbes

Microbiota during pregnancy and early life: role in maternal-neonatal outcomes based on human evidence.

Alessio Fasano, Benoit Chassaing, Dirk Haller, Eduard Flores Ventura, Maria Carmen-Collado, Nitida Pastor, Omry Koren, Roberto Berni Canani

Abstract readReview
In one paragraph

Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessio FasanoMucosal Immunology and Biology Research Center, Mass General Brigham, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0002-2134-0261
Benoit ChassaingMicrobiome-Host Interactions, Institut Pasteur, INSERM, Université Paris Cité, Paris, France.
Dirk HallerNutrition and Immunology, School of Life Sciences, Technical University of Munich, Freising, Germany.
Eduard Flores VenturaDepartment of Biotechnology, Institute of Agrochemistry and Food Technology - Spanish National Research Council (IATA-CSIC), Valencia, Spain.ORCID 0000-0001-9383-7181
Maria Carmen-ColladoDepartment of Biotechnology, Institute of Agrochemistry and Food Technology - Spanish National Research Council (IATA-CSIC), Valencia, Spain.ORCID 0000-0002-6204-4864
Nitida PastorDepartment of Medical Affairs, Clinical Research, Mead Johnson Nutrition, Evansville, IN, USA.
Omry KorenAzrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.ORCID 0000-0002-7738-1337
Roberto Berni CananiDepartment of Translational Medical Science, and ImmunoNutritionLab at Ceinge Advanced Biotechnologies Research Center, and European Laboratory for Investigation of Food Induced Diseases, University of Naples Federico II, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we explored the vast potential of microbiome-based interventions in preventing and managing non-communicable diseases including obesity, diabetes, allergies, celiac disease, inflammatory bowel diseases, malnutrition, and cardiovascular diseases across different life stages. We discuss the intricate relationship between microbiome and non-communicable diseases, emphasizing on the "window of opportunity" for microbe-host interactions during the first years after birth. Specific biotics and also live biotherapeutics including fecal microbiota transplantation emerge as pivotal tools for precision medicine, acknowledging the "one size doesn't' fit all" aspect. Challenges in implementation underscore the need for advanced technologies, scientific transparency, and public engagement. Future perspectives advocate for understanding maternal-neonatal microbiome, exploring the maternal exposome and delving into human milk's role in the establishment and restoration of the infant microbiome and its influence over health and disease. An integrated scientific approach, employing multi-omics and accounting for inter-individual variance in microbiome composition and function appears central to unleash the full potential of early-life microbiome interventions in revolutionizing healthcare.

Indexed as

Gastrointestinal MicrobiomeFecal Microbiota TransplantationFemaleHost Microbial InteractionsHumansInfantInfant, NewbornMilk, HumanPregnancyepigeneticsGut microbiomelive biotherapeuticspostbioticsprebioticsprecision medicineprobioticsshort-chain fatty acids

Identifiers

PMID39161102
PMCPMC11340748

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.